Pramipexole (Prami), 12 mg (0.2 mg/60 capsules)

Pramipexole is a non-ergoline dopamine receptor agonist with preferential affinity for D3 receptors and additional activity at D2 receptor subtypes within the D2-like receptor family. Experimental investigations have examined its interactions with dopamine receptor-mediated signaling pathways, G protein-coupled receptor activation mechanisms, intracellular cAMP regulation, and receptor-ligand dynamics. Its receptor selectivity profile makes it a valuable research tool for studies of D2/D3 receptor pharmacology, dopaminergic signaling networks, receptor subtype selectivity, signal transduction mechanisms, and comparative investigations of dopamine receptor-mediated regulatory pathways.